Cargando…
Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis
Tumour necrosis factor (TNF) signalling is mediated via two receptors, TNF-receptor 1 (TNFR1) and TNF-receptor 2 (TNFR2), which work antithetically to balance CNS immune responses involved in autoimmune diseases such as multiple sclerosis. To determine the therapeutic potential of selectively inhibi...
Autores principales: | Williams, Sarah K., Fairless, Richard, Maier, Olaf, Liermann, Patricia C., Pichi, Kira, Fischer, Roman, Eisel, Ulrich L. M., Kontermann, Roland, Herrmann, Andreas, Weksler, Babette, Romero, Nacho, Couraud, Pierre-Olivier, Pfizenmaier, Klaus, Diem, Ricarda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133964/ https://www.ncbi.nlm.nih.gov/pubmed/30206422 http://dx.doi.org/10.1038/s41598-018-31957-7 |
Ejemplares similares
-
Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis
por: Fiedler, Timon, et al.
Publicado: (2023) -
The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation
por: Richter, Fabian, et al.
Publicado: (2021) -
Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis
por: Williams, Sarah K., et al.
Publicado: (2014) -
Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS
por: Pegoretti, Valentina, et al.
Publicado: (2023) -
The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration
por: Ortí-Casañ, Natalia, et al.
Publicado: (2023)